›Portfolio Companies

Past, Present and Future Leaders

The managing directors of IWHP are proud and privileged to have partnered with visionary management teams who are shaping the future of Biotech, Medical Devices and Healthcare IT. The groundbreaking businesses they have created are representative of the industry-leading companies that InterWest has helped build over the last three decades.

Our Companies

VENTURE INVESTING IN BREAKTHROUGH HEALTHCARE COMPANIES

Trevena

portfoliocompanies

company snapshot

Trevena, Inc. is a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs. Using its proprietary product platform, Trevena has identified three biased ligand product candidates – oliceridine (TRV130) to treat moderate to severe acute pain intravenously (Phase 3), TRV734 to treat moderate to severe acute and chronic pain orally (Phase 1), and TRV250 for acute episodic migraine and other CNS disorders (preclinical).

website
http://www.trevena.com/
Leadership
Follow The Company
Investment Team
Maxine Gowen, Ph.D., President and Chief Executive Officer